ALISON KORTZ: Open Payments
NPI 1619966264 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 68 payments from 16 companies in 2025. Trend: 2023 $2,003 · 2024 $2,503 · 2025 $1,263
Food & beverage: $1,254Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $374 |
| Janssen Biotech, Inc. | 11 | $237 |
| Novartis Pharmaceuticals Corporation | 13 | $214 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $62 |
| UCB, Inc. | 2 | $57 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $37 |
| Amgen Inc. | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
Products named: SKYRIZI, TREMFYA, COSENTYX, RINVOQ, SPEVIGO, Bimzelx, ILUMYA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
